Dividend Assets Capital, LLC Organon & Co. Transaction History

Dividend Assets Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$10.95 - $17.32 $229 - $363	-21 Reduced 14.89%	120 $2,000
Q3 2023 Oct 26, 2023	BUY	$16.59 - $23.77 $16 - $23	1 Added 0.71%	141 $2,000
Q2 2023 Jul 31, 2023	SELL	$19.27 - $24.63 $38 - $49	-2 Reduced 1.41%	140 $3,000
Q4 2022 Feb 10, 2023	SELL	$23.31 - $28.61 $3,170 - $3,890	-136 Reduced 48.92%	142 $4,000
Q2 2022 Jul 15, 2022	SELL	$31.66 - $38.9 $474 - $583	-15 Reduced 5.12%	278 $9,000
Q4 2021 Feb 23, 2022	SELL	$28.67 - $37.13 $573 - $742	-20 Reduced 6.39%	293 $9,000
Q3 2021 Nov 01, 2021	SELL	$28.63 - $35.64 $3,292 - $4,098	-115 Reduced 26.87%	313 $10,000
Q2 2021 Jul 23, 2021	BUY	$28.45 - $38.0 $12,176 - $16,264	428 New	428 $13,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Dividend Assets Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Dividend Assets Capital, LLC with notifications on news.